Skip to main content
SpringerLink
Log in

CABG cost effective in high-risk patients with coronary disease

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. repeat CABG, repeat PCI, stroke, cerebrovascular events, acute myocardial infarction, heart failure, angina pectoris, chest pain or arrhythmia

  2. 2013 Australian dollars

Reference

  • Ariyaratne TV, et al. The Real-World Cost-Effectiveness of Coronary Artery Bypass Surgery Versus Stenting in High-Risk Patients: Propensity Score-Matched Analysis of a Single-Centre Experience. Applied Health Economics and Health Policy : 12 Jul 2018. Available from: URL: http://doi.org/10.1007/s40258-018-0407-5

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

CABG cost effective in high-risk patients with coronary disease. PharmacoEcon Outcomes News 808, 10 (2018). https://doi.org/10.1007/s40274-018-5125-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-5125-6

Search

Navigation